GURUFOCUS.COM » STOCK LIST » Financial Services » Capital Markets » CME Group Inc (NAS:CME) » Definitions » Revenue

CME (CME Group) Revenue : $6,044 Mil (TTM As of Sep. 2024)


View and export this data going back to 2002. Start your Free Trial

What is CME Group Revenue?

CME Group's revenue for the three months ended in Sep. 2024 was $1,584 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was $6,044 Mil. CME Group's Revenue per Share for the three months ended in Sep. 2024 was $4.40. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $16.80.

Good Sign:

CME Group Inc has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of CME Group was 12.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 4.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 5.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, CME Group's highest 3-Year average Revenue per Share Growth Rate was 26.10% per year. The lowest was -2.00% per year. And the median was 6.50% per year.


CME Group Revenue Historical Data

The historical data trend for CME Group's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CME Group Revenue Chart

CME Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,868.00 4,883.60 4,689.70 5,019.40 5,578.90

CME Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,337.80 1,439.30 1,487.90 1,532.50 1,584.40

Competitive Comparison of CME Group's Revenue

For the Financial Data & Stock Exchanges subindustry, CME Group's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CME Group's Revenue Distribution in the Capital Markets Industry

For the Capital Markets industry and Financial Services sector, CME Group's Revenue distribution charts can be found below:

* The bar in red indicates where CME Group's Revenue falls into.



CME Group Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $6,044 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CME Group  (NAS:CME) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


CME Group Revenue Related Terms

Thank you for viewing the detailed overview of CME Group's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CME Group Business Description

Address
20 South Wacker Drive, Chicago, IL, USA, 60606
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
Executives
Elizabeth A Cook director 20 S. WACKER DRIVE, CHICAGO IL 60606
Martin J Gepsman director 20 S. WACKER DR, CHICAGO IL 60606
Timothy S. Bitsberger director 20 S. WACKER DRIVE, CHICAGO IL 60606
Sunil Cutinho officer: President, CME Clearing 20 S. WACKER DR., CHICAGO IL 60606
Timothy Francis Mccourt officer: Sr MD Global Head Equity & FX 20 S WACKER DRIVE, CHICAGO IL 60606
William R Shepard director 20 S. WACKER DR, CHICAGO IL 60606
Lynne Fitzpatrick officer: Sr MD Deputy CFO 20 S WACKER DRIVE, CHICAGO IL 60606
Bryan T Durkin officer: MD & COO 20 S. WACKER DRIVE, CHICAGO IL 60606
Charles P Carey director 20 S. WACKER DRIVE, CHICAGO IL 60606
Daniel R Glickman director 20 S. WACKER DR, CHICAGO IL 60606
Terry L Savage director 20 S. WACKER DRIVE, CHICAGO IL 60606
Hilda Harris Piell officer: MD, Organizational Development 20 S. WACKER DRIVE, CHICAGO IL 60606
Terrence A Duffy director 20 S. WACKER DR, CHICAGO IL 60606
Derek Sammann officer: Managing Dir Financial Product 20 S. WACKER DRIVE, CHICAGO IL 60606
Dennis Suskind director ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282